Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma
Gakis, G. ; Morgan, T. M. ; Daneshmand, S. ; Keegan, K. A. ; Todenhöfer, T. ; Mischinger, J. ; Schubert, T. ; Zaid, H. B. ; Hrbacek, J. ; Ali-El-Dein, B. ; Clayman, R. H. ; Galland, S. ; Olugbade, K. ; Rink, M. ; Fritsche, H.-M ; Burger, M. ; Chang, S. S. ; Babjuk, M. ; Thalmann, G. N. ; Stenzl, A. ; Efstathiou, J. A.
In: Annals of Oncology, 2015, vol. 26, no. 8, p. 1754-1759
Aggiungi alla tua lista- Summary
- This is the first series that suggests a prognostic benefit of neoadjuvant treatment in a consecutive series of patients who underwent perioperative chemotherapy plus surgery for advanced primary urethral carcinoma. Further studies should yield a better understanding of how perioperative chemotherapy exerts a positive effect on survival in order to selectively advocate its use in advanced primary urethral carcinoma